RhumbLine Advisers’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-26,886
Closed -$113K 2942
2018
Q1
$113K Sell
26,886
-1,775
-6% -$9.67K ﹤0.01% 2728
2017
Q4
$159K Sell
28,661
-5,269
-16% -$22.9K ﹤0.01% 2693
2017
Q3
$110K Buy
33,930
+550
+2% +$7.41K ﹤0.01% 2857
2017
Q2
$629K Buy
33,380
+5,523
+20% +$77K ﹤0.01% 2189
2017
Q1
$341K Buy
27,857
+818
+3% +$11.9K ﹤0.01% 2440
2016
Q4
$430K Sell
27,039
-140
-0.5% -$2.34K ﹤0.01% 2306
2016
Q3
$494K Buy
27,179
+300
+1% +$4.9K ﹤0.01% 2210
2016
Q2
$427K Buy
26,879
+10,372
+63% +$155K ﹤0.01% 2298
2016
Q1
$246K Buy
16,507
+2,360
+17% +$37.1K ﹤0.01% 2631
2015
Q4
$393K Buy
14,147
+1,185
+9% +$29.5K ﹤0.01% 2404
2015
Q3
$231K Buy
12,962
+497
+4% +$11.8K ﹤0.01% 2704
2015
Q2
$287K Buy
+12,465
New +$350K ﹤0.01% 2687

Other funds holding OTIC

RhumbLine Advisers's OTIC Position: Q2 2018 in Review

RhumbLine Advisers sold out of Otonomy, Inc. (OTIC) in Q2 2018, closing a stake of 26,886 shares — an estimated $113K sold.

RhumbLine Advisers first reported a position in OTIC in Q2 2015 and held it in 12 quarters. The position peaked at $629K in Q2 2017. 69 funds tracked by Wall St. Rank hold OTIC as of Q2 2018.

  • RhumbLine Advisers reported no remaining Otonomy, Inc. position as of Q2 2018 after selling out during the quarter.
  • RhumbLine Advisers sold 26,886 Otonomy, Inc. shares in Q2 2018, an estimated $113K.
  • RhumbLine Advisers first reported a position in Otonomy, Inc. in Q2 2015 and held it in 12 quarters.
  • RhumbLine Advisers's Otonomy, Inc. position peaked at $629K in Q2 2017.
  • 69 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q2 2018.

Based on RhumbLine Advisers's 13F filing for Q2 2018, filed 6 Aug 2018.